Lynn Seely - President and CEO, Director at Lyell Immunopharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
LYEL on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Lynn Seely - trading volume in the past year for Lyell Immunopharma, Inc.

Holdings reported by Lynn Seely for Lyell Immunopharma, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 713K $432K $0.61 Mar 14, 2025 Direct
Option (right to buy) 169K Feb 10, 2025 Direct Common Stock

Transactions reported by Lynn Seely for Lyell Immunopharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.